Assessing immunization coverage in Southern togo: implications for perennial malaria chemoprevention delivery.

ABSTRACT:

Background

Malaria remains a major health challenge in sub-Saharan Africa, especially for children under five. The World Health Organization (WHO) recommends perennial malaria chemoprevention (PMC) to children in areas of medium to high perennial transmission. In Togo, since 2022, a pilot project has leveraged the Expanded Program on Immunization (EPI) to deliver PMC to children under two years; however, the extent to which PMC achieves its desired outcome may depend on EPI performance. This study assessed EPI coverage and factors associated with zero-dose status in southern Togo.

Methods

We used secondary data from a multi-stage sampling household survey on malaria prevalence conducted in the Haho district in 2022, focusing on children aged 12-23 months. Vaccination history

SUBMITTER: Arikawa S 

PROVIDER: S-EPMC12406404 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature